Risk-COPD study: how do people with COPD experience their risk of lung attacks and heart- and vesselproblems

Risk-COPD: Perspectives of people with COPD on cardiopulmonary risk: a qualitative study. - A qualitative exploration of everyday experiences of cardiopulmonary RISK among patients with COPD: RISK-COPD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON61254

Enrollment

Registered

2026-03-03

Start date

2026-05-15

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, COPD lung disease due to inflammation or damage of the respiratory system

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult – The participant is 18 years old or older. COPD – The participant has a COPD diagnosis according to the GOLD 2026 reportExacerbation history – The participant has experienced at least one exacerbation in the past year.  Cardiopulmonary health risks discussed –  The participant has been informed about cardiopulmonary risk by their medical professional. This includes the risk of future exacerbations and/or cardiovascular events.Ability – The participant is physically and cognitively able to participate in a ~60 minute interview and able to discuss their experience of cardiopulmonary health risks with a researcher. The participant is able to understand the context and goal of the research, and is able to express themselves in Dutch.Written informed consent – The participant has given written informed consent

Exclusion criteria

Exclusion criteria: Vulnerable persons - Patients with cognitive, psychiatric, physical or communication impairments that prevent them from giving informed consent, substantially limit the reliability of the interview, or make participation disproportionately burdensome or unjustifiable in the opinion of the researcher and/or the treating physician.

Design outcomes

Primary

Measure	Time frame
Qualitative description of the experiences of (cardiopulmonary) risks in the lives of people with COPD.Qualitative description of how people with COPD experience clinical advice on cardiopulmonary risk.Qualitative description of how people with COPD experience discussing cardiopulmonary health risks with medical professionals.Qualitative description of how medical professionals discuss cardiopulmonary health risks with people with COPD.	—

Measure

Time frame

Qualitative description of the experiences of (cardiopulmonary) risks in the lives of people with COPD.Qualitative description of how people with COPD experience clinical advice on cardiopulmonary risk.Qualitative description of how people with COPD experience discussing cardiopulmonary health risks with medical professionals.Qualitative description of how medical professionals discuss cardiopulmonary health risks with people with COPD.

—

Countries

Netherlands

Contacts

Public ContactW.L. Beekman

Astra Zeneca

info.nl@astrazeneca.com085-8089900

Outcome results